# O2: FOXP3 Pathogenic Hotspot Enrichment — FINAL STATUS

**Date:** 2026-05-10  
**Status:** SUPPORTED_WITH_CAVEATS  
**Test Method:** Fisher's exact test (zero-cell safe)

---

## Hypothesis

Pathogenic FOXP3 variants are enriched at known hotspot positions compared to benign/VUS variants.

---

## Implemented

**Script:** `scripts/test_O2_foxp3_hotspots.py`  
**Output:** `results/O2_foxp3_hotspots_test.json`

**Data:**
- 276 FOXP3 ClinVar variants (GRCh38)
- 42 pathogenic
- 234 benign/VUS

**Hotspot definition:** Position with ≥2 pathogenic variants

**Statistical test:** Fisher's exact test (two-sided + greater alternative)

---

## Verified Results

**Run date:** 2026-05-10

```
Contingency Table:
                    Hotspot   Non-hotspot
Pathogenic          3         39
Benign/VUS          0         234

Fisher's exact test (greater): p = 0.0033
Odds Ratio (Haldane-corrected): 41.56
95% CI: [2.11, 820.09]
```

**Hotspot identified:**
- chrX:49258295 (GRCh38)
- 3 pathogenic variants at this position
- All at c.210+1 splice donor site

**Why Haldane correction:**
- Zero cell: benign_vus_hotspot = 0
- Standard OR = infinity (unstable)
- Haldane-Anscombe +0.5 correction applied to report finite OR/CI

---

## Caveats

1. **N=1 hotspot only** — Single position (chrX:49258295). Cannot generalize to "FOXP3 hotspots" plural without cross-position validation.

2. **Mechanism expected** — All 3 pathogenic variants are splice donor (c.210+1). High pathogenicity for splice sites is a known VEP category effect, not specific to "hotspot clustering."

3. **X-linked ascertainment bias** — FOXP3 is X-linked. Male hemizygotes overrepresented in ClinVar for X-linked genes → potential ascertainment bias.

4. **Zero benign/VUS at hotspot** — CI is wide [2.11, 820.09] due to zero cell. Result is statistically significant but precision is low.

5. **Not pre-registered in 9-loci manuscript** — FOXP3 was not part of the original 9-loci analysis (HBB, TP53, BRCA1, CFTR, MLH1, TERT, GJB2, GATA1, PTEN).

---

## Verdict

**SUPPORTED_WITH_CAVEATS**

Pathogenic FOXP3 variants show statistically significant enrichment at one splice-donor hotspot (chrX:49258295, Fisher p=0.0033, OR=41.56).

**This result:**
- ✅ Demonstrates Fisher's exact test handles zero cells correctly
- ✅ Confirms splice-site pathogenicity is detectable in ClinVar
- ❌ Does NOT demonstrate general "hotspot clustering" beyond this single position
- ❌ Does NOT add evidence to ARCHCODE manuscript v2 (9-loci scope)

**Interpretation:** This is a **proof-of-method** for hotspot detection, not a broad biological discovery. The result is narrow and mechanism-specific (splice donor).

---

## Recommendations

**For manuscript v2:** Do NOT include O2 result. Violates "9-loci only" scope and adds no value beyond known splice-site pathogenicity.

**For future work (post-freeze):** Cross-locus hotspot analysis across 9 loci would test if hotspot enrichment is general or locus-specific.

**For reproducibility:** Fisher's exact test is the correct choice for rare hotspot events (zero cells common). Script is production-ready.

---

## Files Changed

- `scripts/test_O2_foxp3_hotspots.py` — Fisher's exact implementation ✅
- `results/O2_foxp3_hotspots_test.json` — verified output ✅
- `results/fig_O2_foxp3_hotspots.png` — visualization ✅
- `results/O2_FOXP3_FINAL_STATUS.md` — this document ✅

**No manuscript/results text relies on chi-square or OR=infinity** — verified via grep.

---

**Closed:** 2026-05-10  
**Next:** No expansion. O2 complete.
